Heart failure in the elderly

Journal of Geriatric Cardiology

Volumn 9, Issue 2, 2012, Pages 101-107

  Viana De Freitas, Elizabete ^a,b   Batlouni, Michel ^c,d,e   Gamarsky, Roberto ^b,f  

^a HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^b Pró Cardíaco Hospital   (Brazil)

^c Department of Cardiology ^*  (Brazil)

^d FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^e INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^f FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Elderly people; Geriatric problems; Heart failure; Hypertension

Indexed keywords

AMILORIDE; ANTICOAGULANT AGENT; BISOPROLOL; BUMETANIDE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; HEPARIN; HYDRALAZINE; HYDROCHLOROTHIAZIDE; ISOSORBIDE; LISINOPRIL; PERINDOPRIL; RAMIPRIL; TRIAMTERENE;

ACUTE DISEASE; AGED; AGING; ARTERIOVENOUS FISTULA; ASTHENIA; ATHEROSCLEROSIS; BRADYCARDIA; CHRONIC DISEASE; CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; CONSTIPATION; DELIRIUM; DIAGNOSTIC ACCURACY; DIASTOLIC HEART FAILURE; DIET THERAPY; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; ELECTROCARDIOGRAM; EXERCISE TEST; FATIGUE; FEVER; FLUID RETENTION; GLUCOSE INTOLERANCE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE FUNCTION; HUMAN; HYPERCALCEMIA; HYPERTENSION; HYPERTHYROIDISM; HYPOMAGNESEMIA; HYPONATREMIA; IMMUNIZATION; INFLUENZA VACCINATION; ISCHEMIC CARDIOMYOPATHY; LUNG EMBOLISM; MYOCARDITIS; NAUSEA AND VOMITING; PERICARDIAL DISEASE; PERIPHERAL VASCULAR DISEASE; PLEURA EFFUSION; POLYENDOCRINOPATHY; RISK FACTOR; SKELETAL MUSCLE; SLEEP DISORDER; SMOKING CESSATION; THIAMINE DEFICIENCY; THORAX RADIOGRAPHY; UREMIA; VALVULAR HEART DISEASE;

EID: 84866234643     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1263.2011.12295     Document Type: Conference Paper

References (30)

1. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993; 22(4 Suppl A): 6A-13A. (Pubitemid 23285789)
2. Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994; 72(2 Suppl): S3-S9. (Pubitemid 24249719)
3. Petrie MC, Berry C, Stewart S, et al. Failing aging hearts. Eur Heart J 2001; 22: 1978-1990.
4. Weir RAP, Mcmurray JJV, Taylor J, et al. Heart failure in older patients. Br J Cardiol 2006; 13: 257-266. (Pubitemid 44390263)
5. Abdelhafz AH. Heart failure in older people: causes, diagnosis and treatment. Age Ageing 2002; 31: 29-36.
6. Gillespie ND. The diagnosis and management of chronic heart failure in older patient. Br Med Bull 2006; 75-76: 49-62.
7. Wenger NK. Cardiovascular disease in the elderly. Curr Probl Cardiol 1992; 17: 611-690.
8. Rich MW. Heart failure: Epidemiology, Pathophysiology and Management. In Cardiovascular Disease in the Octogenarium and Beyond; Wenger NK, Ed; Martin Dunitz: London, UK, 1999; 73-91.
9. Gravina CF, Rosa RF, Franken RA, et al. Guidelines in Cardiogeriatrics II of the Brazilian Society of Cardiology. Arq Bras Cardiol 2010; 95(Supl.2): S1-S112.
10. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308-315. (Pubitemid 27298437)
11. Paulus Wj, Tschöpe C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539-2550.
12. Haney S, Sur D, Xu Z. Diastolic heart failure. A review and primary care perspective. J Am Board Fam Med 2005; 18: 189-198. (Pubitemid 41657623)
13. Batlouni M, Freitas EV, Neto Savioli F. Heart Failure in the Elderly. In Treaty of Geriatrics and Gerontology; 3rd Edition; Freitas EV, Py L, Eds.; Rio de Janeiro: Brazil 2011; 462-483.
14. Batlouni M, Savioli Neto F, Magalhães HM. Alterações Farmacocinéticas e Farmacodinâmicas Relacionadas à Idade. Terapêutica Cardiovascular no Idoso. In Farmacologia e Terapêutica Cardiovascular; Batlouni M, Ramires JAF, Eds.; São Paulo: Atheneu 1999: 27-46.
15. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-1140.
16. Davie AP, Francis CM, Love MP, et al. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. Br Med J 1996; 312: 222-227.
17. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation 2005; 112: 1825-1852.
18. The RALES Investigators. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (The Randomized Aldactone Evaluation Study-RALES). Am J Cardiol 1996; 78: 902-907.
19. Goldsmith S, Marx S. Update use of digitalis and nitrates in the elderly. Geriatrics 1988: 43: 71-76.
20. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitails Investigation Group. N Engl J Med 1997; 336: 525-533.
21. Schwartz S, Zipes DP. Cardiovascular disease in special populations. In Treaty of Cardiovascular Disease; Zipes DP, Libby P, Bonow R, et al., Eds; Saunders: New York, 2006; 1925-1949.
22. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 314: 1547-1552. (Pubitemid 16114684)
23. McMurray JJ, Young JB, Dunlap ME, et al. CHARM Investigators. Relationship of dose of background angiotensin- converting enzyme inhibitor to the benefits of candesartan in the Candesartan in heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. Am Heart J 2006; 151: 985-991.
24. Merit-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999; 94: 2807-2816.
25. Packer M, Coats AJS, Fowler MB, et al. Effect of carvedilol in severe chronic heart failure. New Engl J Med 1996; 334; 1349-1355.
26. CIBIS II Investigators and Committies. The Cardiac insufficiency Bisoprol Study: A randodomized trial. Lancet 1999; 353: 9-13.
27. Flather MD, Shibata MC, Coats AJ, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26: 215-225. (Pubitemid 40222359)
28. Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002; 39: 194.
29. Setaro JF, Zaret BL, Schulman DS, et al. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990; 66: 981-986. (Pubitemid 20360593)
30. Warner JG Jr., Metzger DC, Kitzman DW, et al. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999; 33: 1567-1572.